Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × inavolisib × Clear all

Phase

Status

Recruiting 15 Active not recruiting 5 Not yet recruiting 2 Withdrawn 1 Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 1 Breast Neoplasms 1

Interventions

Cyclophosphamide 337 Carboplatin 286 pembrolizumab 268 Gemcitabine 268 Cisplatin 261 Radiotherapy 252 Paclitaxel 251 Docetaxel 245 Bevacizumab 210 Rituximab 200 Capecitabine 187 Nivolumab 179 Dexamethasone 169 Fluorouracil 168 fludarabine 154 Oxaliplatin 148 Doxorubicin 134 Irinotecan 126 Leucovorin 125 Etoposide 123 Pemetrexed 122 Cytarabine 121 Bortezomib 107 fludarabine phosphate 106 Cetuximab 105 Lenalidomide 102 Filgrastim 102 Erlotinib Hydrochloride 98 Temozolomide 93 Radiosurgery 93

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04849364 2025-05-31

PERSEVERE

Hoosier Cancer Research Network

Phase 2 Terminated

52 enrolled 16 charts

Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡